(Q33282750)

25 July 2017

title

Simple, mammalian cell-based assay for identification of inhibitors of the Erk MAP kinase pathway (English)

1 reference

25 July 2017

Pavel Krejci

1

0 references

author name string

Katerina Pejchalova

series ordinal

2

1 reference

25 July 2017

William R Wilcox

series ordinal

3

1 reference

25 July 2017

publication date

26 April 2007

1 reference

Investigational New Drugs

25 July 2017

published in

1 reference

25 July 2017

volume

25

1 reference

25 July 2017

issue

4

1 reference

25 July 2017

page(s)

391-395

1 reference

Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene

25 July 2017

cites work

1 reference

12 December 2020

Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer

1 reference

12 December 2020

Mutations of the BRAF gene in human cancer

1 reference

12 December 2020

The MAPK signaling cascade

1 reference

12 December 2020

Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis

1 reference

12 December 2020

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

1 reference

12 December 2020

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation

1 reference

12 December 2020

Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells

1 reference

12 December 2020

Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies

1 reference

12 December 2020

Cell responses to FGFR3 signalling: growth, differentiation and apoptosis

1 reference

12 December 2020

Integrating the MAP kinase signal into the G1 phase cell cycle machinery

1 reference

12 December 2020

FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells

1 reference

12 December 2020

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors

1 reference

12 December 2020

Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes

1 reference

12 December 2020

Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery

1 reference

12 December 2020

Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins

1 reference

12 December 2020

10.1007/S10637-007-9054-7

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

1045948511

0 references

1 reference